Related Experiment Video
Updated: Jun 7, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Suppression of intestinal neoplasia by DNA hypomethylation
P W Laird1, L Jackson-Grusby, A Fazeli
1Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge 02142, USA.
Abstract:
We have used a combination of genetics and pharmacology to assess the effects of reduced DNA methyltransferase activity on ApcMin-induced intestinal neoplasia in mice. A reduction in the DNA methyltransferase activity in Min mice due to heterozygosity of the DNA methyltransferase gene, in conjunction with a weekly dose of the DNA methyltransferase inhibitor 5-aza-deoxycytidine, reduced the average number of intestinal adenomas from 113 in the control mice to only 2 polyps in the treated heterozygotes. Hence, DNA methyltransferase activity contributes substantially to tumor development in this mouse model of intestinal neoplasia. Our results argue against an oncogenic effect of DNA hypomethylation. Moreover, they are consistent with a role for DNA methyltransferase in the generation of the C to T transitions seen at high frequency in human colorectal tumors.
Insights
Reducing DNA methyltransferase activity significantly decreased intestinal tumors in mice. This suggests DNA methyltransferase contributes to tumor development and may play a role in colorectal cancer mutations.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- ApcMin mice are a model for intestinal neoplasia.
- DNA methyltransferase (DNMT) activity is crucial in epigenetic regulation.
- The role of DNMT in intestinal tumor development requires further elucidation.
Purpose of the Study:
- To investigate the impact of reduced DNA methyltransferase activity on ApcMin-induced intestinal neoplasia in mice.
- To determine if DNA hypomethylation contributes to tumor development.
Main Methods:
- Utilized a combination of genetic modification (DNMT heterozygosity) and pharmacological inhibition (5-aza-deoxycytidine) in ApcMin mice.
- Quantified the number of intestinal adenomas in control versus treated groups.
Main Results:
- Reduced DNMT activity in heterozygote Min mice led to a dramatic decrease in intestinal adenomas, from an average of 113 to just 2 polyps.
- This highlights a substantial contribution of DNMT activity to tumor development in this model.
Conclusions:
- DNA methyltransferase activity plays a significant role in the development of intestinal tumors in the ApcMin mouse model.
- The findings do not support an oncogenic role for DNA hypomethylation.
- Results align with DNMT's role in generating C to T transitions observed in human colorectal cancers.
Related Concept Videos
Epigenetic Regulation
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

